Michael L. Nieder

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2008 · 734 citations · Full text

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2005 · 711 citations · Full text

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)

ON Koç, John Day, Michael L. Nieder et al. · Bone Marrow Transplantation · 2002 · 656 citations

Regenerative Medicine, Cell Therapy, Bone Marrow Failure +13

Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.

Ian Magrath, Magdalena Adde, Aziza Shad et al. · Journal of Clinical Oncology · 1996 · 485 citations

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma

Alexander J. Chou, Eugenie S. Kleinerman, Mark Krailo et al. · Cancer · 2009 · 237 citations · Full text